[SYRS] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
10-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -154.12%
YoY- 36.87%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 386 3,762 2,833 2,954 -5,467 3,891 6,276 -84.33%
PBT -64,384 -40,143 -36,258 -23,789 -4,774 -30,253 -34,481 51.46%
Tax 10,883 -3,296 1,278 -8,865 -32,349 -9,201 712 512.85%
NP -64,384 -40,143 -36,258 -14,924 27,575 -21,052 -35,193 49.41%
Tax Rate - - - - - - - -
Total Cost 64,770 43,905 39,091 17,878 -33,042 24,943 41,469 34.50%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -16,679.79 -1,067.07 -1,279.84 -505.21 -504.39 -541.04 -560.76 854.09%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -2.18 -1.43 -1.30 -0.54 0.99 -2.24 -5.51 -46.01%
EPS Diluted -2.18 -1.43 -1.30 -0.54 0.99 -2.24 -5.51 -46.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.